Skip to main content
. 2007 Feb 22;9(1):R18. doi: 10.1186/ar2127

Figure 4.

Figure 4

Concentrations of receptor activator of nuclear factor-kappa-B ligand (RANKL), osteoprotegerin (OPG), and prostaglandin E2 (PGE2) in synovial fluids (SFs) from patients with a loose prosthesis or with osteoarthritis (OA). RANKL (a) and OPG (b) in SFs were analysed with commercially available enzyme-linked immunosorbent assays. (c) PGE2 in SFs was analysed with a commercially available radio-immunoassay.